• Happy Holidays from Cafepharma! To allow its staff to spend holiday time with their families, the Cafepharma Message Boards will be switched to read-only from 6:00 PM Eastern time on Tuesday, December 24 until 10:00 PM Eastern time on Wednesday, December 25. During this time, all posts will be available for view. However, no one will be able to make new posts during this time.


patent

  1. Sandoz wins the patent case against Allergan

    This is the second patent win for Sandoz in December 2017. Allergan is expected to file for rehearing within 30 days on patent ruling. Earlier in Dec., Sandoz also won a patent case against Amgen.
    • anonymous
    • Thread
    • allergan amgen lawsuit novartis patent sandoz
    • Replies: 0
    • Forum: Novartis

  2. Lilly in the migraine drug race

    http://alph.st/bf3c0558 Lilly joins the migraine drug race with Novartis and Amgen, as FDA accepts to review Lilly's Galcanezumab. Already, Teva filed a lawsuit in October 2017, seeking to block Lilly's migraine drug to market in the U.S. The size of the migraine market is expected to more than...
    • anonymous
    • Thread
    • amgen eli lilly fda lawsuit migraine novartis patent pfizer teva
    • Replies: 8
    • Forum: Eli Lilly

  3. Mylan wins the battle

    Texas court says Allergan's Mohawk Tribe patent deal is invalid. Earlier, Mylan had fired back at rival Allergan's attempt to shield its patent for Restasis.
    • anonymous
    • Thread
    • deal mylan patent
    • Replies: 1
    • Forum: Mylan

  4. Allergan gets a major blow

    Texas court says Mohawk Tribe patent deal is not legit. "The Court has serious concerns about the legitimacy of the tactic that Allergan and the Tribe have employed," Judge William Bryson said in a memorandum opinion accompanying his decision.
    • anonymous
    • Thread
    • allergan deal patent
    • Replies: 2
    • Forum: Allergan

  5. Settles with Pfizer's subsidiary on Restasis patent

    Allergan reaches a settlement with InnoPharma, a subsidiary of Pfizer on Restasis patent. Out of the four contestants, Mylan, Teva and Akorn are still contesting the patents in the federal court. http://alph.st/b3437240
    • anonymous
    • Thread
    • agreement allergan lawsuit patent pfizer settlement
    • Replies: 2
    • Forum: Allergan

  6. Patent dispute win

    Lilly wins Alimta patent challenge. Also, Lilly had won Alimta patent battle against Actavis in July 2017.
    • anonymous
    • Thread
    • cancer treatment eli lilly oncology patent
    • Replies: 0
    • Forum: Eli Lilly

  7. Shire sues Allergan. Who will win?

    After selling Restasis patent to Mohawk Indians, Allergan is playing against its opponent Shire. Shire's Xiidra vs. Allergan's Restasis. Who will win?
    • anonymous
    • Thread
    • allergan lawsuit patent shire
    • Replies: 15
    • Forum: Shire

  8. Shire sues Allergan. Restasis vs. Xiidra

    After selling Restasis patent to Mohawk Indians, Allergan is playing the game very well.
    • anonymous
    • Thread
    • allergan lawsuit patent shire
    • Replies: 0
    • Forum: Allergan

  9. Senators ask for investigation on Mohawk Tribe deal

    Four senators, including Sherrod Brown ask for investigation on Mohawk Tribe deal.
    • anonymous
    • Thread
    • allergan patent
    • Replies: 2
    • Forum: Allergan

  10. Allergan patent litigation

    Allergan reaches a settlement with Famy Care and it will grant Famy Care a license to market generic version of Restasis in U.S. in 2024.
    • anonymous
    • Thread
    • agreement allergan drugs litigation patent
    • Replies: 0
    • Forum: Allergan

  11. Reflections on Life in Romark

    Romark is an interesting place, it has one product in 2 formulations since 2004. It is a private company so company books are not truly open. We believe what they tell us, or not. The patents are up and they have not moved ahead with any "new" product, just investigating a line extension which...
    • anonymous
    • Thread
    • off label patent
    • Replies: 16
    • Forum: Romark

  12. Cialis drug's "erectile dysfunction"

    Cialis, a drug that is used to treat impotence, was given for a free trial for the first time users in 2004. Now the patent for Cialis expires earlier than the previous date.
Top Bottom
Back